Standard Biotools (LAB) Market Capitalization (2011 - 2026)

Standard Biotools (LAB) has reported Market Capitalization for 16 consecutive years, with $321.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 29.8% year-over-year to $321.5 million in Q2 2026; TTM through Jun 2026 was $321.5 million, a 29.8% decrease from a year earlier, with the FY2025 full-year figure at $494.6 million, down 25.14% from the prior year.
• Market Capitalization was $321.5 million for Q2 2026 at Standard Biotools, down from $358.7 million in the prior quarter.
• Over five years, Market Capitalization peaked at $797.1 million in Q1 2024 and troughed at $87.2 million in Q3 2022.
• A 5-year average of $370.6 million and a median of $340.1 million in 2026 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization tumbled 82.71% in 2022 and soared 419.7% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $93.0 million in 2022, then surged by 90.67% to $177.3 million in 2023, then surged by 272.61% to $660.7 million in 2024, then slipped by 25.14% to $494.6 million in 2025, then sank by 34.99% to $321.5 million in 2026.
• The last three Market Capitalization figures came in at $321.5 million (Q2 2026), $358.7 million (Q1 2026), and $494.6 million (Q4 2025), per Business Quant data.